Literature DB >> 1984760

Psychiatric disorders in relatives of probands with opiate addiction.

B J Rounsaville1, T R Kosten, M M Weissman, B Prusoff, D Pauls, S F Anton, K Merikangas.   

Abstract

Previous research has documented high rates of major depression and antisocial personality in opiate addicts. This study was designed to investigate the relationship of dual diagnosis in opiate-addicted probands to family history of psychiatric disorders and substance use disorders in biological relatives. Psychiatric disorders and substance use disorders were evaluated using direct interview and family history in a sample of 877 first-degree relatives of 201 opiate addicts and 360 relatives of 82 normal controls. Results indicate that (1) compared with relatives of normal subjects, opiate addicts' relatives had substantially higher rates of alcoholism, drug abuse, depression, and antisocial personality; (2) relatives of depressed opiate-addicted probands had elevated rates of major depression and anxiety disorders but not of other disorders, suggesting the validity of subtyping opiate addicts by the presence or absence of major depression; and (3) in contrast, relatives of antisocial opiate addicts had rates of disorders that were not significantly different from those of relatives of opiate addicts without antisocial personality. Implications of these findings for the classification and treatment of substance abuse are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1984760     DOI: 10.1001/archpsyc.1991.01810250035004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  31 in total

1.  The differential impact of risk factors on illicit drug involvement in females.

Authors:  Arpana Agrawal; Charles O Gardner; Carol A Prescott; Kenneth S Kendler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

2.  Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins.

Authors:  Kenneth S Kendler; Steven H Aggen; Kristian Tambs; Ted Reichborn-Kjennerud
Journal:  Psychol Med       Date:  2006-05-02       Impact factor: 7.723

3.  Is there heterogeneity among syndromes of substance use disorder for illicit drugs?

Authors:  Cheryl Beseler; Kristen C Jacobson; William S Kremen; Michael J Lyons; Stephen J Glatt; Stephen V Faraone; Nathan A Gillespie; Ming T Tsuang
Journal:  Addict Behav       Date:  2006-05-12       Impact factor: 3.913

Review 4.  Neuropsychological consequences of opiate use.

Authors:  Staci A Gruber; Marisa M Silveri; Deborah A Yurgelun-Todd
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

Review 5.  Genetic factors influencing alcohol dependence.

Authors:  R D Mayfield; R A Harris; M A Schuckit
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

6.  The causes of parent-offspring transmission of drug abuse: a Swedish population-based study.

Authors:  K S Kendler; H Ohlsson; K Sundquist; J Sundquist
Journal:  Psychol Med       Date:  2014-05-14       Impact factor: 7.723

Review 7.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

8.  The longitudinal impact of HIV+ parents' drug use on their adolescent children.

Authors:  Patricia E Lester; Robert E Weiss; Eric Rice; W Scott Comulada; Lynwood Lord; Susan Alber; Mary Jane Rotheram-Borus
Journal:  Am J Orthopsychiatry       Date:  2009-01

9.  Within-family environmental transmission of drug abuse: a Swedish national study.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Kristina Sundquist; Jan Sundquist
Journal:  JAMA Psychiatry       Date:  2013-02       Impact factor: 21.596

10.  Impact of Family History in Persons With Dual Diagnosis.

Authors:  Camille S Wilson; Melanie E Bennett; Alan S Bellack
Journal:  J Dual Diagn       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.